Walter 2016
Walter 2016
Walter 2016
Intussusception Hospitalizations
Emmanuel B. Walter, MD, MPH,a Mary Allen Staat, MD, MPHb
aDuke
COMMENTARY
ABBREVIATIONS
RV1:monovalent rotavirus vaccine
RV5:pentavalent rotavirus vaccine
REFERENCES
1. Ruiz-Palacios GM, Prez-Schael
I, Velzquez FR, et al; Human
Rotavirus Vaccine Study Group.
Safety and efcacy of an attenuated
vaccine against severe rotavirus
gastroenteritis. N Engl J Med.
2006;354(1):1122
2. Vesikari T, Matson DO, Dennehy P,
et al; Rotavirus Efcacy and Safety Trial
(REST) Study Team. Safety and efcacy
of a pentavalent human-bovine (WC3)
reassortant rotavirus vaccine. N Engl J
Med. 2006;354(1):2333
3. Carlin JB, Macartney KK, Lee KJ,
et al. Intussusception risk and disease
prevention associated with rotavirus
vaccines in Australias National
Immunization Program. Clin Infect Dis.
2013;57(10):14271434
4. Haber P, Parashar UD, Haber M,
DeStefano F. Intussusception after
monovalent rotavirus vaccineUnited
References
Subspecialty Collections
Reprints
The online version of this article, along with updated information and services, is
located on the World Wide Web at:
/content/138/3/e20161952.full.html
Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.
Alternative Proxies: